ID

31833

Description

Study ID: 105229 Clinical Study ID: GLP105229 Study Title: A double-blinded, randomized, placebo-controlled, staggered-parallel, escalating dose study to investigate the safety, tolerability, pharmacokinetics and pharmacodynamics of subcutaneous injections of GSK 716155 in healthy volunteers. Patient Level Data: Study Listed on ClinicalStudyDataRequest.com Clinicaltrials.gov Identifier: Sponsor: GlaxoSmithKline Collaborators: N/A Phase: Phase 1 Study Recruitment Status: Completed Generic Name: albiglutide Trade Name: Tanzeum,Eperzan Study Indication: Diabetes Mellitus, Type 2

Keywords

Versions (1)
  1. 10/1/18 10/1/18 -
Copyright Holder

GlaxoSmithKline

Uploaded on

October 1, 2018

DOI

To request one please log in.

License

Creative Commons BY-NC 3.0
Model comments :

You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.

Back to model comments
Itemgroup comments for :

Item comments for :

  • Newest
  • Oldest
  • Popular
  • Newest
    • Newest
    • Oldest
    • Popular

No comments

In order to download data models you must be logged in. Please log in or register for free.

Subcutaneous injections of GSK 716155 in healthy volunteers; Study ID: 105229

English

Concomitant Medication

1 forms  
  1. StudyEvent: ODM
    1. Concomitant Medication
Concomitant Medication
Description

Concomitant Medication

Alias
UMLS CUI-1
C2347852
Were any concomitant medications taken by the subject prior to screening and/or during the study?
Description

Concomitant Agent Before Screening procedure; Concomitant Agent During Clinical Trials

Data type

boolean

Alias
UMLS CUI [1,1]
C2347852
UMLS CUI [1,2]
C0332152
UMLS CUI [1,3]
C0220908
UMLS CUI [2,1]
C2347852
UMLS CUI [2,2]
C0347984
UMLS CUI [2,3]
C0008976
Drug Name
Description

Concomitant agent; medication name

Data type

text

Alias
UMLS CUI [1,1]
C2347852
UMLS CUI [1,2]
C2360065
Unit Dose
Description

Concomitant agent; dosage

Data type

float

Alias
UMLS CUI [1,1]
C2347852
UMLS CUI [1,2]
C0178602
Unit
Description

Concomitant agent; Unit

Data type

text

Alias
UMLS CUI [1,1]
C2347852
UMLS CUI [1,2]
C0439148
Frequency
Description

Concomitant agent; Frequency

Data type

text

Alias
UMLS CUI [1,1]
C2347852
UMLS CUI [1,2]
C3476109
Route
Description

Concomitant agent; Drug Administration Routes

Data type

text

Alias
UMLS CUI [1,1]
C2347852
UMLS CUI [1,2]
C0013153
Reason for Medication
Description

Concomitant agent; Indication

Data type

text

Alias
UMLS CUI [1,1]
C2347852
UMLS CUI [1,2]
C3146298
Start Date
Description

Concomitant agent; Start Date

Data type

date

Alias
UMLS CUI [1]
C2826734
Start Time
Description

Concomitant agent; Start Time

Data type

time

Alias
UMLS CUI [1,1]
C2347852
UMLS CUI [1,2]
C1301880
Taken prior to study?
Description

Concomitant agent; before; clinical trial period

Data type

boolean

Alias
UMLS CUI [1,1]
C2347852
UMLS CUI [1,2]
C0332152
UMLS CUI [1,3]
C2347804
Stop date
Description

Concomitant agent; Stop date

Data type

date

Alias
UMLS CUI [1,1]
C2347852
UMLS CUI [1,2]
C0806020
Stop time
Description

Concomitant agent; Stop time

Data type

time

Alias
UMLS CUI [1,1]
C2347852
UMLS CUI [1,2]
C1522314
Ongoing medication?
Description

Concomitant medication ongoing

Data type

boolean

Alias
UMLS CUI [1]
C2826666
Back to the top of the page

Similar models

Concomitant Medication

1 forms
  1. StudyEvent: ODM
    1. Concomitant Medication
Name
Type
Description | Question | Decode (Coded Value)
Data type
Alias
Item Group
Concomitant Medication
C2347852 (UMLS CUI-1)
Concomitant Agent Before Screening procedure; Concomitant Agent During Clinical Trials
Item
Were any concomitant medications taken by the subject prior to screening and/or during the study?
boolean
C2347852 (UMLS CUI [1,1])
C0332152 (UMLS CUI [1,2])
C0220908 (UMLS CUI [1,3])
C2347852 (UMLS CUI [2,1])
C0347984 (UMLS CUI [2,2])
C0008976 (UMLS CUI [2,3])
Concomitant agent; medication name
Item
Drug Name
text
C2347852 (UMLS CUI [1,1])
C2360065 (UMLS CUI [1,2])
Concomitant agent; dosage
Item
Unit Dose
float
C2347852 (UMLS CUI [1,1])
C0178602 (UMLS CUI [1,2])
Concomitant agent; Unit
Item
Unit
text
C2347852 (UMLS CUI [1,1])
C0439148 (UMLS CUI [1,2])
Concomitant agent; Frequency
Item
Frequency
text
C2347852 (UMLS CUI [1,1])
C3476109 (UMLS CUI [1,2])
Concomitant agent; Drug Administration Routes
Item
Route
text
C2347852 (UMLS CUI [1,1])
C0013153 (UMLS CUI [1,2])
Concomitant agent; Indication
Item
Reason for Medication
text
C2347852 (UMLS CUI [1,1])
C3146298 (UMLS CUI [1,2])
Concomitant agent; Start Date
Item
Start Date
date
C2826734 (UMLS CUI [1])
Concomitant agent; Start Time
Item
Start Time
time
C2347852 (UMLS CUI [1,1])
C1301880 (UMLS CUI [1,2])
Concomitant agent; before; clinical trial period
Item
Taken prior to study?
boolean
C2347852 (UMLS CUI [1,1])
C0332152 (UMLS CUI [1,2])
C2347804 (UMLS CUI [1,3])
Concomitant agent; Stop date
Item
Stop date
date
C2347852 (UMLS CUI [1,1])
C0806020 (UMLS CUI [1,2])
Concomitant agent; Stop time
Item
Stop time
time
C2347852 (UMLS CUI [1,1])
C1522314 (UMLS CUI [1,2])
Concomitant medication ongoing
Item
Ongoing medication?
boolean
C2826666 (UMLS CUI [1])
Back to the top of the page 

Contact

Please use this form for feedback, questions and suggestions for improvements.

Fields marked with * are required.

Help

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial